BRAF and polycystic kidney disease: The results showed that their combination simultaneously inhibited glycolysis and oxidative phosphorylation metabolism in polycystic kidney epithelial cells, significantly decreased glucose intake, lactate production and ATP yield, and significantly decreased the activation levels of proliferation signaling pathway molecules, including mTOR, B-Raf-ERK and PKA.